JP2020509763A5 - - Google Patents

Download PDF

Info

Publication number
JP2020509763A5
JP2020509763A5 JP2019549562A JP2019549562A JP2020509763A5 JP 2020509763 A5 JP2020509763 A5 JP 2020509763A5 JP 2019549562 A JP2019549562 A JP 2019549562A JP 2019549562 A JP2019549562 A JP 2019549562A JP 2020509763 A5 JP2020509763 A5 JP 2020509763A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid construct
host cell
nucleotide sequence
exogenous nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019549562A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020509763A (ja
JP7177076B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/051572 external-priority patent/WO2018167621A1/en
Publication of JP2020509763A publication Critical patent/JP2020509763A/ja
Publication of JP2020509763A5 publication Critical patent/JP2020509763A5/ja
Application granted granted Critical
Publication of JP7177076B2 publication Critical patent/JP7177076B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019549562A 2017-03-16 2018-03-09 チロシン原栄養性 Active JP7177076B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762472225P 2017-03-16 2017-03-16
US62/472,225 2017-03-16
US201862628018P 2018-02-08 2018-02-08
US62/628,018 2018-02-08
PCT/IB2018/051572 WO2018167621A1 (en) 2017-03-16 2018-03-09 Tyrosine prototrophy

Publications (3)

Publication Number Publication Date
JP2020509763A JP2020509763A (ja) 2020-04-02
JP2020509763A5 true JP2020509763A5 (https=) 2021-04-08
JP7177076B2 JP7177076B2 (ja) 2022-11-22

Family

ID=61802237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019549562A Active JP7177076B2 (ja) 2017-03-16 2018-03-09 チロシン原栄養性

Country Status (5)

Country Link
US (1) US20200056190A1 (https=)
EP (1) EP3596206A1 (https=)
JP (1) JP7177076B2 (https=)
CA (1) CA3056182A1 (https=)
WO (1) WO2018167621A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2999224C (en) * 2015-09-23 2023-10-24 Pfizer Inc. Cells and method of cell culture
JP7423521B2 (ja) 2017-11-22 2024-01-29 モダーナティエックス・インコーポレイテッド フェニルケトン尿症の治療用のフェニルアラニンヒドロキシラーゼをコードするポリヌクレオチド
CN111902164A (zh) 2018-02-01 2020-11-06 同源药物公司 用于恢复pah基因功能的腺相关病毒组合物及其使用方法
EP3870604B1 (en) 2018-10-26 2022-11-23 F. Hoffmann-La Roche AG Multispecific antibody screening method using recombinase mediated cassette exchange
SG11202109830TA (en) 2019-03-13 2021-10-28 Generation Bio Co Non-viral dna vectors and uses thereof for expressing phenylalanine hydroxylase (pah) therapeutics
EP4058583A1 (en) * 2019-11-14 2022-09-21 Lonza Ltd. Methods of cell selection
TW202208632A (zh) 2020-05-27 2022-03-01 美商同源醫藥公司 用於恢復pah基因功能的腺相關病毒組成物及其使用方法
US20230235298A1 (en) * 2020-06-01 2023-07-27 Modernatx, Inc. Phenylalanine hydroxylase variants and uses thereof
EP4301861A1 (en) 2021-03-03 2024-01-10 Shape Therapeutics Inc. Auxotrophic cells for virus production and compositions and methods of making

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4713339A (en) * 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4754065A (en) 1984-12-18 1988-06-28 Cetus Corporation Precursor to nucleic acid probe
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
GB8601597D0 (en) 1986-01-23 1986-02-26 Wilson R H Nucleotide sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US5166320A (en) 1987-04-22 1992-11-24 University Of Connecticut Carrier system and method for the introduction of genes into mammalian cells
US5422120A (en) 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biologicals S A Expression of retrovirus gag protein eukaryotic cells
JP2752788B2 (ja) 1989-01-23 1998-05-18 カイロン コーポレイション 感染および過剰増殖障害の為の組換え療法
ES2116269T3 (es) 1989-03-21 1998-07-16 Vical Inc Expresion de secuencias exogenas de polinucleotidos en un vertebrado.
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
JP4041535B2 (ja) 1989-08-18 2008-01-30 オックスフォード バイオメディカ(ユーケー)リミテッド 標的細胞にベクター構造体を運搬する組換レトロウィルス
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
DK0494955T3 (da) 1989-10-05 1998-10-26 Optein Inc Cellefri syntese og isolering af hidtil ukendte gener og polypeptider
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
ZA911974B (en) 1990-03-21 1994-08-22 Res Dev Foundation Heterovesicular liposomes
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
JP3534749B2 (ja) 1991-08-20 2004-06-07 アメリカ合衆国 アデノウイルスが介在する胃腸管への遺伝子の輸送
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
GB9125623D0 (en) 1991-12-02 1992-01-29 Dynal As Cell modification
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
EP0650370A4 (en) 1992-06-08 1995-11-22 Univ California METHODS AND COMPOSITIONS TARGETED ON SPECIFIC TISSUES.
CA2137361A1 (en) 1992-06-10 1993-12-23 W. French Anderson Vector particles resistant to inactivation by human serum
GB2269175A (en) 1992-07-31 1994-02-02 Imperial College Retroviral vectors
AU680459B2 (en) 1992-12-03 1997-07-31 Genzyme Corporation Gene therapy for cystic fibrosis
PT695169E (pt) 1993-04-22 2003-04-30 Skyepharma Inc Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao
ES2249761T3 (es) 1993-06-24 2006-04-01 Advec Inc. Vectores de adenovirus para terapia genica.
ES2328424T3 (es) 1993-09-15 2009-11-12 Novartis Vaccines And Diagnostics, Inc. Vectores de alfavirus recombinantes.
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
EP1637608B1 (en) 1993-10-25 2009-07-22 CANJI, Inc. Recombinant adenoviral vector and methods of use
PT729351E (pt) 1993-11-16 2000-12-29 Skyepharma Inc Vesiculas com libertacao controlada de activos
WO1995030763A2 (en) 1994-05-09 1995-11-16 Chiron Viagene, Inc. Retroviral vectors having a reduced recombination rate
AU4594996A (en) 1994-11-30 1996-06-19 Chiron Viagene, Inc. Recombinant alphavirus vectors
WO1997042338A1 (en) 1996-05-06 1997-11-13 Chiron Corporation Crossless retroviral vectors
AU2001242302A1 (en) 2000-03-14 2001-09-24 Nilab Aps Method of treating phenylketonuria and means therefor
SI2371392T1 (sl) 2002-05-02 2015-10-30 Wyeth Holdings Llc Konjugati derivat-nosilec kaliheamicina
WO2010132341A2 (en) * 2009-05-11 2010-11-18 Pfenex, Inc. Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporation of non-natural amino acids therein
WO2012027533A1 (en) 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
WO2012145682A1 (en) 2011-04-21 2012-10-26 Amgen Inc. A method for culturing mammalian cells to improve recombinant protein production
DK2714936T3 (en) * 2011-06-01 2019-03-25 Prec Biosciences Inc METHODS AND PRODUCTS FOR PRODUCING MANIPULATED MAMMAL CELL LINES WITH AMPLIFIED TRANSGENES
EP2711428A1 (en) 2012-09-21 2014-03-26 Lonza Biologics plc. Site-specific integration
US20160230200A1 (en) * 2013-09-05 2016-08-11 Danmarks Tekniske Universitet Microorganisms for efficient production of melatonin and related compounds
RS60359B1 (sr) * 2014-06-06 2020-07-31 Regeneron Pharma Postupci i kompozicije za modifikovanje ciljanog lokusa
CA2999224C (en) * 2015-09-23 2023-10-24 Pfizer Inc. Cells and method of cell culture

Similar Documents

Publication Publication Date Title
JP2020509763A5 (https=)
CN107435051B (zh) 一种通过CRISPR/Cas9系统快速获得大片段缺失的细胞系基因敲除方法
JP7103603B2 (ja) Ch3ドメインに基づくヘテロダイマー分子、その調製方法及び用途
JP2018518957A5 (https=)
CA2502385A1 (en) Il-1 receptor based antagonists and methods of making and using
CN102703424B (zh) 一种重组工程介导的大肠杆菌基因组点突变的方法
CN108424907A (zh) 一种高通量dna多位点精确碱基突变方法
RU2007124369A (ru) Производство белков
EP3159411B1 (en) Vector comprising gene fragment for enhancement of recombinant protein expression and use thereof
JP2008505626A5 (https=)
US9752159B2 (en) Stable expression system for eukaryotic cells
CN119177222B (zh) 一种吡咯赖氨酰-tRNA合成酶突变体及其应用
CN107723287B (zh) 一种增强丝蛋白生产制备的表达系统
RU2013123638A (ru) Рекомбинантная плазмидная днк, кодирующая химерное антитело против фактора некроза опухоли-альфа человека, линия эукариотических клеток - продуцент химерного антитела и способ получения химерного антитела
JP2026510174A (ja) 切断されたインスレーターおよびその使用
CN1382692A (zh) 小麦高分子量麦谷蛋白14亚基基因的核酸序列及其应用
US11136598B2 (en) Method for cell line development
CN101541959A (zh) 用于增加转录的基质附着区(mar)及其应用
CN104404069A (zh) 一种低拷贝pTerm质粒及其构建方法和应用
CN103060367A (zh) 一种离体高效构建多拷贝乳酸克鲁维酵母表达载体的方法
CN114774421A (zh) 运动发酵单胞菌内源性启动子突变体
WO2025141778A1 (ja) 新規プロモーター
JP2022546709A (ja) 大腸菌に基づく組換え株ならびにその構築方法および使用
WO2020204055A1 (ja) 標的特異的な外来遺伝子の導入方法
CN104120119B (zh) 一种3-脱氢奎尼酸合成酶突变体及其基因和应用